Full-Time

Manager – Inspection Management

Posted on 9/10/2024

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

Biotechnology
Healthcare

Senior

Cambridge, MA, USA + 2 more

More locations: Princeton, NJ, USA | Bethesda, MD, USA

Job is not fully remote; specific locations include Cambridge, MA; Princeton, NJ; and Bethesda, MD.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Google Cloud Platform
Requirements
  • BS/BA, MS or PhD and a minimum of 10, 8, 6 years’ experience, respectively, in Biotech, Pharma or Clinical Research Organization.
  • 8+ years experience in Inspection Management/Audit/Quality Management
  • Knowledge of relevant FDA, EU, ICH GCP guidelines, and applicable international GxP regulations, guidelines and local legislation.
  • Knowledge of relevant FDA, EU, guidance for computerized systems is a plus.
  • Working knowledge of relevant GVP regulations, guidelines and local legislation preferred.
  • Experience interfacing with agencies on inspection coordination and logistical planning for regulatory authority inspections.
  • Experience developing responses to regulatory authority inspection findings.
  • Experience working with CROs, vendors, and relationship management.
  • Strong leadership skills with ability to effectively organize and execute tasks.
  • Ability to interact effectively with all levels within the organization.
  • Ability to work both independently and in a team environment.
  • Excellent analytical, problem solving and decision-making skills in a complex, fast-paced, and changing environment.
  • Excellent communication and presentation skills, both verbal and written.
  • Excellent auditing skills and ability to communicate significant observations to Auditees in a sound and factual manner.
  • Ability to solve complex problems taking a broad perspective to identify innovative solutions.
  • Ability to manage multiple projects in a fast-paced environment.
  • Ability to collaborate effectively in a dynamic, cross-functional matrix environment.
  • Ability to influence and negotiate effective solutions, excellent interpersonal skills.
Responsibilities
  • Partner closely with members of R&D to lead and support the successful and compliant execution of Moderna regulatory authority inspection activities in the region.
  • Actively participate as a key member of the inspection team in Regulatory Authority inspections (GCP, GVP) within the region including inspection planning, logistics, preparation training and support; actively support during the inspection and provide expert guidance and direction in development of responses to inspection observations and regulatory agency questions resulting from inspections.
  • Ensure any critical and major inspection findings have appropriate Corrective and Preventative Actions (CAPA) and are tracked to completion and verification of effectiveness.
  • Review and provide input into study team inspection readiness activities, storyboards, etc.
  • Provide education, guidance and/or inspection management training for GCP functional areas and clinical operations teams.
  • Provide input into the issue management program to ensure early detection of issues, development of appropriate and robust corrective and preventative actions (CAPA), tracking of CAPA completion, and assessment of effectiveness is attained.
  • Execute and report GCP investigator site, study, system/process, and vendor audits and GVP vendors, system, affiliate, partner audits, as necessary, and work with Moderna staff to ensure the proposed corrective and preventative actions received from the auditees are appropriate and implemented.
  • Contribute to the R&D Quality Regulatory Intelligence program.
  • Contribute to the R&D Quality Newsletter.
  • Participate in Moderna projects and initiatives.
  • Contribute to the continuing development of a quality culture at Moderna.
  • Additional duties as may be assigned from time to time.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for various biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treatment options for patients. Unlike traditional pharmaceuticals, which often rely on small molecules or proteins, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to leverage the unique properties of mRNA to improve patient outcomes and create a new category of effective treatments.

Company Stage

IPO

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

2010

Growth & Insights
Headcount

6 month growth

4%

1 year growth

16%

2 year growth

55%
Simplify Jobs

Simplify's Take

What believers are saying

  • Opening a new vaccine facility in Victoria enhances manufacturing capabilities.
  • Strategic investment in China boosts Moderna's presence in the Asian market.
  • Collaboration with Carisma Therapeutics could lead to breakthroughs in autoimmune treatments.

What critics are saying

  • Potential removal from Nasdaq 100 could impact investor perception.
  • Reticence in Hong Kong for Covid-19 jab indicates market penetration challenges.
  • Expansion into China may expose Moderna to geopolitical and regulatory risks.

What makes Moderna unique

  • Moderna is pioneering mRNA technology for innovative medical treatments.
  • The company has a strong focus on developing vaccines for infectious diseases.
  • Moderna's mRNA platform enables rapid development of therapeutics and vaccines.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE